AORT

Artivion, Inc.

• Simply Wall St·5d ago

  Artivion (AORT) Is Up 10.1% After Full FDA PMA Approval for AMDS Aortic Device

• Simply Wall St·6d ago

  Artivion (AORT) Wins FDA Approval, Is The Stock Still 53% Undervalued?

• NASDAQ·07/02 14:09

  Weekly Buzz: VRTX, APTX Gain FDA Nod; UNCY Disappoints; Ipsen Opens Wallet; VTGN Misses Goal

• Seeking Alpha·06/30 13:30

  Artivion: PMA Approval Supports Accelerating Growth And Margin Expansion

• TipRanks·06/30 11:15

  Artivion Earns Buy Rating as AMDS Wins Broader FDA Approval; Analyst Reiterates $36 Price Target

• Benzinga·06/29 17:38

  Artivion Seeks To Tap $150 Million US Market Opportunity With FDA Approval

• Simply Wall St·06/29 17:29

  Why Artivion (AORT) Is Up 17.3% After Full FDA PMA Approval for AMDS Hybrid Prosthesis

• NASDAQ·06/29 15:39

  Artivion Gains FDA PMA Approval For AMDS Hybrid Prosthesis In Treating Aortic Dissections

• TipRanks·06/29 15:15

  Artivion: FDA Approval Expands AMDS Market Opportunity; Buy Rating Reiterated with Unchanged $44 Price Target

• TipRanks·06/29 12:50

  Analysts Are Bullish on These Healthcare Stocks: LifeMD (LFMD), Artivion (AORT)

• NASDAQ·06/29 12:25

  Artivion Wins FDA Approval For AMDS Hybrid Prosthesis

• Benzinga·06/29 11:13

  Artivion Says FDA Approves Premarket Approval Application For AMDS Hybrid Prosthesis

• PR Newswire·06/29 11:00

  Artivion Announces U.S. FDA Approval of the AMDS Hybrid Prosthesis

• Seeking Alpha·06/24 14:20

  10 small-cap U.S. healthcare stocks with the weakest momentum grades

• TipRanks·06/23 09:40

  Analysts Offer Insights on Healthcare Companies: Artivion (AORT) and Pfizer (PFE)